VRTX Stock: Vertex Pharmaceuticals Incorporated Stock Price, Analysis & Insights
Get live VRTX stock price $438.53, comprehensive Vertex Pharmaceuticals Incorporated stock analysis, charts, news, and expert forecast. Real-time VRTX stock data and investment insights.
Loading chart data...
Vertex Pharmaceuticals Incorporated (VRTX) Overview
Vertex Pharmaceuticals Incorporated (VRTX) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, VRTX trades at $438.53 with a market capitalization of 111.30B . Over the past 52 weeks, VRTX has traded between $362.50 and $507.92 , with the current price positioned at approximately 52% of this range . The stock...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 111.30B
- Current price: $438.53
- 52-week range: $362.50 - $507.92
- P/E ratio: 26.06
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Vertex Pharmaceuticals Incorporated is a leading biotechnology firm primarily focused on the discovery, advancement, and marketing of innovative treatments, particularly for cystic fibrosis (CF). The company offers a range of approved medications for...
Company Information
- CEO
- Reshma Kewalramani
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 6100
Contact Information
- Website
- https://www.vrtx.com
- Address
- 50 Northern Avenue
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Market leader with 111.3 billion market capitalization
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 26.1)
✓ Lower volatility stock (Beta: 0.31) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Vertex Pharmaceuticals Incorporated shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Vertex Pharmaceuticals Incorporated
- ⚠Investors should consider how Vertex Pharmaceuticals Incorporated fits within their overall portfolio allocation
Market Cap
111.30B
P/E Ratio (TTM)
26.06
Beta
0.31
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare VRTX with peer companies:
- Price
- $877.21
- Market cap
- 54.28B
- Price
- $56.01
- Market cap
- 114.37B
- Price
- $97.20
- Market cap
- 124.02B
- Price
- $51.07
- Market cap
- 102.70B
- Price
- $374.52
- Market cap
- 83.08B
- Price
- $791.94
- Market cap
- 95.19B
- Price
- $80.98
- Market cap
- 103.97B
- Price
- $609.61
- Market cap
- 62.80B
- Price
- $43.78
- Market cap
- 105.26B
- Price
- $311.10
- Market cap
- 119.26B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.